Hitachi Chemical Diagnostics Renamed Minaris Medical America prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Smart Glass Market Size Worth $7.5 Billion By 2028 | CAGR: 6.8%: Grand View Research, Inc.
SAN FRANCISCO, March 16, 2021 /PRNewswire/ The global smart glass market size is expected
to reach USD 7.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand
at a CAGR of 6.8% from 2021 to 2028. The growing demand across the transportation and architectural sectors is expected to fuel the market growth over the forecast period. Moreover, the growing trend of using smart technology in new buildings has propelled the demand for smart glass products in the architectural sector.
Key suggestions from the report:
The increasing number of stringent regulations, such as the green building initiative by the European Union and the Building Energy Conservation Act, is expected to drive the market over the forecast period
Smart Glass Market Size Worth $7 5 Billion By 2028 | CAGR: 6 8%: Grand View Research, Inc prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy
GENEVA, Switzerland and MUNICH, Germany, February 22, 2021 / B3C newswire / MaxiVAX SA, a private Swiss clinical-stage biotech company developing novel anti-cancer vaccines, and Minaris Regenerative Medicine GmbH (“Minaris”), a leading contract development and manufacturing service provider for the cell and gene therapy industry, have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of cancers such as chordoma, head and neck, and other solid tumors.
The MVX-ONCO-2 consists of two components: 1) biocompatible capsules, loaded with a genetically modified cell-line that secretes a strong immune-booster GM-CSF (granulocyte-macrophage stimulating factor) and 2) irradiated autologous patients’ tumor cells, isolated from patients which serve as tumor antigens. To induce an efficient anti-tumor response against the pa
(2)
PUNE, India, Dec. 17, 2020 /PRNewswire/
The UV cured resins market was valued at US$ 3662.24 Mn in 2019 and is anticipated to witness a compound annual growth rate of 8.9% over the forecast period.
The outbreak of the covid-19 is positively influencing the growth of global UV cured resins market. UV curable resins enhances the adhesive strength and showcases exceptional compatibility with metals, plastics and other materials. The specific property is incrementing its demand across medical industries, for manufacturing of products in high volumes.
Request for Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request sample.php?id=750
The rising adoption of digitization among manufacturers to connect with clients directly rather than depending upon intermediaries is influencing the adoption direct online channels among UV cured resin manufactures, thereby, contributing to the growth of the market across the globe.